Literature DB >> 10843208

Synthesis and evaluation of antiproliferative activity of a geldanamycin-Herceptin immunoconjugate.

R Mandler1, E Dadachova, J K Brechbiel, T A Waldmann, M W Brechbiel.   

Abstract

Geldanamycin was modified with 1,4-diaminobutane to introduce a primary amine that was subsequently employed to provide a maleimide for protein linkage. Monoclonal antibody Herceptin was then derivatized to generate thiol groups that reacted with the maleimide derivative to produce the immunoconjugate. The product showed antiproliferative activity greater than native Herceptin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843208     DOI: 10.1016/s0960-894x(00)00155-4

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates.

Authors:  Yuji Kasuya; Zheng-Rong Lu; Pavla Kopecková; S Esmail Tabibi; Jindrich Kopecek
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

2.  Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides.

Authors:  Motohiro Nonaka; Hideaki Mabashi-Asazuma; Donald L Jarvis; Kazuhiko Yamasaki; Tomoya O Akama; Masato Nagaoka; Toshio Sasai; Itsuko Kimura-Takagi; Yoichi Suwa; Takashi Yaegashi; Chun-Teng Huang; Chizuko Nishizawa-Harada; Michiko N Fukuda
Journal:  PLoS One       Date:  2021-01-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.